|Articles|May 1, 2002
- Applied Clinical Trials-05-01-2002
Identifying and Documenting Adverse Events at Clinical Study Sites
Improving adverse event reporting can lead to improved safety profiles and, consequently, fewer drugs pulled from the market.
Advertisement
Articles in this issue
over 23 years ago
Letters to the Editorover 23 years ago
Parents for Orphansover 23 years ago
Fraud, Abuse, and Consentover 23 years ago
Brian Koziolover 23 years ago
A Model-Based Method for Improving Protocol QualityNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Managing Operational and Compliance Challenges on Emerging Platforms
2
The Future is Now: Four Ways AI and Other Tech Advances are Enhancing Clinical Trials
3
Tech-Enabled Clinical Trials: Simplifying Complexity, Elevating Experience
4
AbbVie and Genmab Secure FDA Approval for Epkinly Combination in Second-Line Plus Follicular Lymphoma
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
